Alternative Medications Might Help With Chronic Pain
As an assistant professor of anesthesiology and a pain researcher, I study alternative pain management options.
Indian State Medical Board Members Discuss Physician Discipline
AAPI and ATMGUSA hosted a videoconference that gathered many of the Indian state medical board members for a live discussion.
COVID Benefits Vanish, But Paid Sick Leave Remains
In a nation divided about government health mandates during the pandemic, the public has been warming to the idea of ...
Understanding the Hair Growth Cycle
Understanding the hair growth cycle stages is crucial for maintaining healthy and vibrant hair. The cycle consists of three main ...
Why We Don’t Have Socialized Medicine
As we grapple with the complexities of healthcare in America, one cannot help but wonder why we still do not ...
Business of Denying Medical Care
By denying coverage for high-risk individuals or expensive treatments, insurance companies can reduce their exposure to financial losses.
Pandemic Led to Greater Medicaid Coverage
The loss of Medicaid coverage among Americans eligible for both Medicare and Medicaid was reduced during COVID emergency.
Stress Cardiomyopathy Mortality From Opioid Cessation
This form of cardiomyopathy involves a complex interplay of factors that we may not normally associate with heart problems.
Circadian Based Intermittent Fasting
Circadian-based intermittent fasting cycles have gained popularity in recent years as a way to improve health and aid in weight ...
Oregon Medicaid Provides Air Conditioners
Recipients must meet federal guidelines that categorize them as “facing certain life transitions,” a stringent set of requirements.
Home Remedies for Acne Scars
Introduction Dealing with acne scars can be a long journey. While there are numerous medical interventions available, many individuals begin ...
Dissolvable Erectile Dysfunction Tablets
Dissolvable erectile dysfunction tablets offer a promising new option for individuals struggling with ED with their convenience.
Semaglutide and the Expansion Problem: When One Trial Becomes a Platform
Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...
Read more